In conclusion, combined US-guided FNAC and FNA-Tg/serum Tg can improve the accuracy of diagnosing CLN metastases in patients with thyroid cancer by compensating for the deficiencies of each technique. The gene discussed is TG; the disease is thyroid gland carcinoma.